A Long-term Study to Describe the Use of PASCORBIN® 7.5 g in Patients With Vitamin C Deficiency

• Status: Recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this long-term observational study is the documentation of the use of PASCORBIN® 7.5 g in patients with vitamin C deficiency. Regarding the vitamin C deficiency, the investigators focus on the acquisition of data of the underlying diseases and the reduction of symptoms, that are related to oxidative stress and vitamin-C-deficiency. Next to this, exact assessment of medical tolerance and details of treatment requirements are further aims. Here the investigators take into account acute and chronic underlying medical conditions. Further health economic data are collected.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pascoe Pharmazeutische Praeparate GmbH
• Treatments: Ascorbic Acid; Vitamins

Criteria

Inclusion Criteria:

• patients with vitamin C deficiency

• patients >= 12 years old

Exclusion Criteria:

• an oxalate urolithiasis,

• iron storage disorders (thalassemia, hemochromatosis, sideroblastic anemia) or have received recently transfused packed red blood cells

• under 12 years of age or

• are pregnant or breastfeeding.